BlackRock Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.13M | Buy |
27,940
+1,700
| +6% | +$130K | ﹤0.01% | 1432 |
|
|
2016
Q3 | $2.19M | Buy |
26,240
+425
| +2% | +$35.4K | ﹤0.01% | 1384 |
|
|
2016
Q2 | $2.13M | Buy |
25,815
+2,156
| +9% | +$178K | ﹤0.01% | 1372 |
|
|
2016
Q1 | $1.8M | Sell |
23,659
-444,082
| -95% | -$33.7M | ﹤0.01% | 1432 |
|
|
2015
Q4 | $37.6M | Sell |
467,741
-878,475
| -65% | -$70.6M | 0.04% | 370 |
|
|
2015
Q3 | $85.5M | Sell |
1,346,216
-5,172
| -0.4% | -$329K | 0.09% | 216 |
|
|
2015
Q2 | $95.1M | Buy |
1,351,388
+44,298
| +3% | +$3.12M | 0.1% | 204 |
|
|
2015
Q1 | $104M | Buy |
1,307,090
+89,100
| +7% | +$7.06M | 0.11% | 207 |
|
|
2014
Q4 | $77.5M | Buy |
1,217,990
+39,400
| +3% | +$2.51M | 0.08% | 251 |
|
|
2014
Q3 | $70.4M | Sell |
1,178,590
-59,397
| -5% | -$3.55M | 0.07% | 266 |
|
|
2014
Q2 | $66.3M | Sell |
1,237,987
-5,700
| -0.5% | -$305K | 0.06% | 284 |
|
|
2014
Q1 | $75M | Buy |
1,243,687
+1,236,297
| +16,729% | +$74.6M | 0.07% | 265 |
|
|
2013
Q4 | $392K | Buy |
7,390
+297
| +4% | +$15.8K | ﹤0.01% | 2196 |
|
|
2013
Q3 | $328K | Buy |
7,093
+80
| +1% | +$3.7K | ﹤0.01% | 2204 |
|
|
2013
Q2 | $288K | Buy |
+7,013
| New | +$288K | ﹤0.01% | 2229 |
|